August 13, 2020
Driving digital diagnosis. Roche and Israeli life sciences investment firm aMoon announced plans this week to launch an early-stage investment program called StarFinder Lab. Focused on novel diagnostic technologies, in particular, with the help of AI data analysis and digital health tools, the program will provide funding, mentoring and other strategic support such as a physical office space...
June 1, 2016
Roche Diagnostics has launched a Bluetooth-connected device for testing blood coagulation in Europe. The CoaguChek INRange system has received a CE Mark, and an older version of the device without the Bluetooth connectivity is already available in the US and in Europe.
The Bluetooth connectivity allows patients undergoing Vitamin K antagonist therapy to self-monitor their blood coagulation with a...
December 7, 2015
French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer. Specifically, the app will help patients and clinicians manage the side effects of a combination therapy of the drugs cediranib and olaparib, which can cause hypertension and diarrhea.
"AstraZeneca has a strong focus on the use of companion devices in drug...
September 30, 2015
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
September 1, 2015
Pictured above: A device from Cambridge-based MC10, a company focused on flexible electronics.
The US Department of Defense is making a big bet on flexible electronics, an area of technology with close ties to mobile health. The DoD announced last week that it will invest $75 million in a public-private partnership called the Manufacturing Innovation Institute for Flexible Hybrid Electronics,...
January 29, 2015
Less than a month after announcing its partnership with Novartis, Qualcomm is adding another big pharmaceutical company to its list of 2net partners: Roche, who will use Qualcomm Life's 2net platform to capture patient data from connected devices, starting with anti-coagulation meters.
“This collaboration marks a significant milestone for Roche as we launch a new generation of point-of-care...
August 4, 2009
Diabetes management tools just got a step closer to medical device interoperability.
A few hours after news broke that A&D Medical's Bluetooth-enabled blood pressure cuff and Bluetooth-enabled weight scale had received Continua Health Alliance's stamp of interoperability, the organization announced that Roche Diagnostics' Accu-Chek Smart Pix Device Reader, which currently interfaces with...
July 21, 2009
The Continua Health Alliance has added three companies to its board of directors: Qualcomm, Ascension Health and CA. The industry alliance of now more than 200 healthcare and technology companies works to ensure global interoperability between personal telehealth solutions.
Continua's board of directors already includes representation from Cisco, Intel, Medtronic, Kaiser Permanente, Panasonic,...
July 1, 2009
MYLEstone Health, developer of the Glucose Buddy iPhone app, is working with Roche Diagnostics' Accu-Chek to add its educational program to the Glucose Buddy diabetes management app. Even though the addition of Accu-Chek's educational program to the iPhone app is a far cry from meter integration, MYLEstone co-founder Matthew Tendler told mobihealthnews, it is a step in the right direction and it...